ebix logo.jpg
EbixCash Wins Long-term Bus Exchange Contract from North Bengal State Transport Corporation
September 28, 2022 07:44 ET | Ebix, Inc.
NOIDA, India and JOHNS CREEK, Ga., Sept. 28, 2022 (GLOBE NEWSWIRE) -- EbixCash Private Limited, a subsidiary of Ebix, Inc. (NASDAQ: EBIX), a leading international supplier of On-Demand software and...
Cytokinetics_Logo_RGB (1).jpg
Cytokinetics Announces Call for Proposals for Its Fifth Annual Communications Grant Program
September 28, 2022 07:30 ET | Cytokinetics, Incorporated
Program to Provide $100,000 in Support of Communications and Outreach for Patient Advocacy Organizations Focused on Cardiovascular and Neuromuscular Diseases Deadline for Applications is November...
Logo low res.JPG
Reunion Neuroscience Inc. Appoints Greg Mayes as President and Chief Executive Officer
September 28, 2022 07:30 ET | Reunion Neuroscience Inc.
TORONTO, Sept. 28, 2022 (GLOBE NEWSWIRE) -- Reunion Neuroscience Inc. (TSX: REUN, NASDAQ: REUN) ("Reunion" or the “Company”), a leader in novel psychedelic drug development committed to innovating...
NEW Nephros DkBlueRGB.png
Nephros Partners with Donastar and Tractor Beverage Company to Supply and Service Nationwide Fast-Casual Restaurant Operation
September 28, 2022 07:30 ET | Nephros, Inc.
SOUTH ORANGE, NJ, Sept. 28, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration and pathogen detection solutions to the...
KemPharm Logo
KemPharm Announces Positive Topline Data from Phase 1 Clinical Trial Evaluating Cardiovascular Safety of Serdexmethylphenidate (SDX)
September 28, 2022 07:30 ET | KemPharm
SDX administered at single doses of 80 mg and 200 mg was well-tolerated CELEBRATION, Fla., Sept. 28, 2022 (GLOBE NEWSWIRE) -- KemPharm, Inc. (NasdaqGS: KMPH) (KemPharm, or the Company), a specialty...
Altimmune logo.png
Altimmune Announces First Dosing of All Subjects in Phase 2 MOMENTUM Trial of Pemvidutide in Subjects with Obesity or Overweight
September 28, 2022 07:30 ET | Altimmune, Inc
GAITHERSBURG, Md., Sept. 28, 2022 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced the completion of first dosing of all subjects in its...
ReWalk Takes Another Step Toward Medicare Coverage
September 28, 2022 07:15 ET | ReWalk Robotics Ltd.
ReWalk to submit first cases for Medicare coverage through Medicare Administrative Contractors (MACs)Centers for Medicare and Medicaid Services (CMS) affirms that the MACs have discretion to cover and...
OraSure Technologies, Inc. Logo
OraSure Technologies Receives $8.6 Million BARDA Contract to Develop 2nd Generation Ebola Test
September 28, 2022 07:05 ET | OraSure Technologies, Inc.
BETHLEHEM, Pa., Sept. 28, 2022 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a global leader in point-of-care and home diagnostic testing and sample collection technologies,...
akoustis tm.jpg
Akoustis Receives Fourth Design Win for a New 5G Mobile Network Infrastructure XBAW Filter
September 28, 2022 07:00 ET | Akoustis, Inc.
Akoustis 3.5 GHz XBAW Filter to be Used in Base Station Equipment for 5G Connectivity in Europe, and AsiaApplication is for Small Cell & MIMO Applications using Multiple XBAW Filters per Base...
Verizon Business Takes 5G Innovation Sessions Series to Boston
September 28, 2022 07:00 ET | Verizon Sourcing LLC
BASKING RIDGE, N.J., Sept. 28, 2022 (GLOBE NEWSWIRE) -- Verizon Business will demonstrate the transformative benefits of its business and public sector solutions at the next installment of its 5G...